These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10360744)

  • 21. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines.
    Chen A; Cauchon E; Chefson A; Dolman S; Ducharme Y; Dubé D; Falgueyret JP; Fournier PA; Gagné S; Gallant M; Grimm E; Han Y; Houle R; Huang JQ; Hughes G; Jûteau H; Lacombe P; Lauzon S; Lévesque JF; Liu S; Macdonald D; Mackay B; McKay D; Percival MD; St-Jacques R; Toulmond S
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3976-81. PubMed ID: 21641209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton.
    Kozikowski AP; Araldi GL; Boja J; Meil WM; Johnson KM; Flippen-Anderson JL; George C; Saiah E
    J Med Chem; 1998 May; 41(11):1962-9. PubMed ID: 9599245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of orally bioavailable alkyl amine renin inhibitors.
    Xu Z; Cacatian S; Yuan J; Simpson RD; Jia L; Zhao W; Tice CM; Flaherty PT; Guo J; Ishchenko A; Singh SB; Wu Z; McKeever BM; Scott BB; Bukhtiyarov Y; Berbaum J; Mason J; Panemangalore R; Cappiello MG; Bentley R; Doe CP; Harrison RK; McGeehan GM; Dillard LW; Baldwin JJ; Claremon DA
    Bioorg Med Chem Lett; 2010 Jan; 20(2):694-9. PubMed ID: 19959358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermodynamics of the interaction of inhibitors with the binding site of recombinant human renin.
    Epps DE; Cheney J; Schostarez H; Sawyer TK; Prairie M; Krueger WC; Mandel F
    J Med Chem; 1990 Aug; 33(8):2080-6. PubMed ID: 2197411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substituted piperidines as HDM2 inhibitors.
    Ma Y; Lahue BR; Shipps GW; Brookes J; Wang Y
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1026-30. PubMed ID: 24486134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piperidine glycosides targeting the ribosomal decoding site.
    Simonsen KB; Ayida BK; Vourloumis D; Winters GC; Takahashi M; Shandrick S; Zhao Q; Hermann T
    Chembiochem; 2003 Sep; 4(9):886-90. PubMed ID: 12964164
    [No Abstract]   [Full Text] [Related]  

  • 27. A practical synthesis of renin inhibitor MK-1597 (ACT-178882) via catalytic enantioselective hydrogenation and epimerization of piperidine intermediate.
    Molinaro C; Shultz S; Roy A; Lau S; Trinh T; Angelaud R; O'Shea PD; Abele S; Cameron M; Corley E; Funel JA; Steinhuebel D; Weisel M; Krska S
    J Org Chem; 2011 Feb; 76(4):1062-71. PubMed ID: 21250716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate specificity and inhibitor structure-activity relationships of recombinant human renin: implications in the in vivo evaluation of renin inhibitors.
    Evans DB; Cornette JC; Sawyer TK; Staples DJ; de Vaux AE; Sharma SK
    Biotechnol Appl Biochem; 1990 Apr; 12(2):161-75. PubMed ID: 2184838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.
    Łazewska D; Kuder K; Ligneau X; Camelin JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2009 Apr; 17(8):3037-42. PubMed ID: 19329325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renin inhibitor SC-51106 complexed with human renin: discovery of a new binding site adjacent to P3.
    Hanson GJ; Clare M; Summers NL; Lim LW; Neidhart DJ; Shieh HS; Stevens AM
    Bioorg Med Chem; 1994 Sep; 2(9):909-18. PubMed ID: 7712126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory activities of baicalin against renin and angiotensin-converting enzyme.
    Deng YF; Aluko RE; Jin Q; Zhang Y; Yuan LJ
    Pharm Biol; 2012 Apr; 50(4):401-6. PubMed ID: 22136493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of 3D QSAR CoMFA/CoMSIA and in silico docking studies on novel renin inhibitors against cardiovascular diseases.
    Politi A; Durdagi S; Moutevelis-Minakakis P; Kokotos G; Papadopoulos MG; Mavromoustakos T
    Eur J Med Chem; 2009 Sep; 44(9):3703-11. PubMed ID: 19410337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure-activity relationships of human renin inhibitors designed from angiotensinogen transition state.
    Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Etoh Y; Shimaoka I; Tsubaki A; Murakami M; Yamaguchi T
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2487-93. PubMed ID: 2285979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piperidine-based heterocyclic oxalyl amides as potent p38 alpha MAP kinase inhibitors.
    Mavunkel BJ; Perumattam JJ; Tan X; Luedtke GR; Lu Q; Lim D; Kizer D; Dugar S; Chakravarty S; Xu YJ; Jung J; Liclican A; Levy DE; Tabora J
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1059-62. PubMed ID: 20031411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of highly potent renin inhibitors potentially interacting with the S3' subsite of renin.
    Sun X; Wen X; Chen YY; Shi C; Gao C; Wu Y; Wang LJ; Yang XH; Sun H
    Eur J Med Chem; 2015 Oct; 103():269-88. PubMed ID: 26363506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel approach of fragment-based lead discovery applied to renin inhibitors.
    Tawada M; Suzuki S; Imaeda Y; Oki H; Snell G; Behnke CA; Kondo M; Tarui N; Tanaka T; Kuroita T; Tomimoto M
    Bioorg Med Chem; 2016 Nov; 24(22):6066-6074. PubMed ID: 27720325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iminopyrimidinones: a novel pharmacophore for the development of orally active renin inhibitors.
    McKittrick BA; Caldwell JP; Bara T; Boykow G; Chintala M; Clader J; Czarniecki M; Courneya B; Duffy R; Fleming L; Giessert R; Greenlee WJ; Heap C; Hong L; Huang Y; Iserloh U; Josien H; Khan T; Korfmacher W; Liang X; Mazzola R; Mitra S; Moore K; Orth P; Rajagopalan M; Roy S; Sakwa S; Strickland C; Vaccaro H; Voigt J; Wang H; Wong J; Zhang R; Zych A
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1592-6. PubMed ID: 25728416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds.
    Matter H; Scheiper B; Steinhagen H; Böcskei Z; Fleury V; McCort G
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5487-92. PubMed ID: 21840215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptors.
    Zimmerman DM; Leander JD; Cantrell BE; Reel JK; Snoddy J; Mendelsohn LG; Johnson BG; Mitch CH
    J Med Chem; 1993 Oct; 36(20):2833-41. PubMed ID: 8410998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.